DAVID PENGILLY: Open Payments
NPI 1710099114 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 90 payments from 16 companies in 2025. Trend: 2023 $1,521 · 2024 $1,605 · 2025 $1,388
Food & beverage: $1,388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $319 |
| PFIZER INC. | 19 | $228 |
| Amgen Inc. | 18 | $195 |
| AstraZeneca Pharmaceuticals LP | 2 | $178 |
| Dexcom, Inc. | 5 | $105 |
| Astellas Pharma US Inc | 3 | $71 |
| Phathom Pharmaceuticals, Inc. | 6 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
Products named: BREZTRI, VRAYLAR, NURTEC ODT, ELIQUIS, QULIPTA, Dexcom G6 Transmitter, OTEZLA, EVENITY.
Industry payments across ND — which companies pay providers there.
